USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Alcon Inc.

USPTO PatentsView assignee record - 793 granted patents across 107 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Alcon ranks #567 of 49,997 tracked US assignees by granted-patent volume, with 793 patents across 107 technology areas.

#567
of 49,997 US assignees by volume
Top 1%
by Innovation Score (67.4/100)
15.0
avg claims per patent
+64300%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R567 · Foreign Corporation #567 · 793 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MID 793 grants
  • TOP-DECILE #567/49,997
  • PHOTO-FINISH Bally Gaming
  • CPC-WIDE A61F · 107 areas
  • INNOV-STRONG 67.4/100
  • CLAIMS-RICH 15.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +64300% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bally Gaming, Inc. (±1 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Alcon

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Alcon's Innovation Score is 67.4/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Alcon's grant cadence moved

Between 2020–2024, Alcon Inc. received 644 grants versus 1 in 2015–2019 (+64300% equal-window velocity, top decile growth). Across complete PatentsView years, output peaked in 2021 at 144 grants and bottomed in 2015 at 1. Lead class A61F accounts for 61.7% of the portfolio across 107 subclasses. Volume neighbours: B/E Aerospace, Inc. (#563) and Abbott Diabetes Care Inc. (#571).

Alcon's three-year grant acceleration

From 2019–2021 to 2022–2024, Alcon Inc. moved from 253 to 391 grants (1.54x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #414. See the growth leaderboard.

Who files at Alcon's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Alcon holds 793 patents at rank #567, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Alcon

By rank, the assignees closest to #567 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Alcon's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Alcon, neither rank-band nor same-CPC leaders (those blocks stay above).

Alcon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

67 Top 1% higher than 99% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

050100150200 2015202020212022202320242025 148
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Alcon Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 0.1%
2020 109 13.7%
2021 144 18.2%
2022 123 15.5%
2023 134 16.9%
2024 134 16.9%
2025partial year 148 18.7%

Which technologies does Alcon Inc. patent most?

Top 15 of 107 technology areas

Where it ranks

Overall rank by patents

#567

of 49,997 tracked assignees

Innovation Score

67.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Alcon Inc.'s patent record in context - here's where to go next.

  • Alcon Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 61.7% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #567 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Alcon Inc. against B/E Aerospace, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 67.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.